ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of bluebird bio, Inc.
Provided By PR Newswire
Last update: Feb 21, 2025
NEW YORK, Feb. 21, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by bluebird bio, Inc. (NASDAQ: BLUE) and its board of directors concerning the proposed acquisition of the company by Carlyle (NASDAQ: CG) and SK Capital Partners, LP. Stockholders will receive $3.00 and a contingent value right of $6.84 for each share of bluebird bio stock that they hold. The transaction is expected to close in the first half of 2025.
Read more at prnewswire.com4.08
-2.96 (-42.05%)
49.86
-2.15 (-4.13%)
Find more stocks in the Stock Screener
BLUE Latest News and Analysis
a day ago - ChartmillTop movers analysis one hour before the close of the markets on 2025-02-21: top gainers and losers in today's session.Here are the top movers in Friday's session, showcasing the stocks with significant price changes.
2 days ago - ChartmillTop movers in Friday's sessionWondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
2 days ago - ChartmillGapping stocks in Friday's sessionThe market is filled with gapping stocks in Friday's session. Let's discover which stocks are showing gap-ups and gap-downs.
2 days ago - ChartmillThese stocks are moving in today's pre-market sessionLet's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top gainers and losers in today's pre-market session.
